Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 33

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

The Effect of a Very-Low-Calorie Diet (VLCD) vs. a Moderate Energy Deficit Diet in Obese Women with Polycystic Ovary Syndrome (PCOS)—A Randomised Controlled Trial

Deshmukh, Harshal, Papageorgiou, Maria, Wells, Liz, Akbar, Shahzad, Strudwick, Thomas, Deshmukh, Ketki, Vitale, Salvatore Giovanni, Rigby, Alan, Vince, Rebecca V., Reid, Marie, Sathyapalan, Thozhukat·2023·Nutrients

Abstract

We performed an open-label, randomised controlled trial to compare the effects of a very-low-calorie diet (VLCD) vs. moderate energy deficit approach on body weight, body composition, free androgen index (FAI), and metabolic markers in obese women with polycystic ovary syndrome (PCOS). Forty eligible patients were randomly assigned to a VLCD (n = 21) or a conventional energy deficit approach (n = 19) over the same period. After eight weeks, both groups experienced significant weight loss; however, this was greater in the VLCD arm (−10.9% vs. −3.9%, p < 0.0001). There was also a trend towards a reduction in FAI in the VLCD group compared to the energy deficit group (−32.3% vs. −7.7%, p = 0.07). In the VLCD arm, two women (18%) had a biochemical remission of PCOS (FAI < 4); this was not the case for any of the participants in the energy deficit arm. There was a significant within-group increase in the sex-hormone-binding globulin (p = 0.002) and reductions in fasting blood glucose (p = 0.010) and waist to hip ratio (p = 0.04) in the VLCD arm, but not in the energy deficit arm. The VLCD resulted in significantly greater weight reduction and was accompanied by more pronounced improvements in hyperandrogenaemia, body composition, and several metabolic parameters in obese women with PCOS as compared to the energy deficit approach.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15183872

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 28

  1. Wolf, W.M., Wattick, R.A., Kinkade, O.N., and Olfert, M.D. (2018). Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. Int. J. Environ. Res. Public Health, 15. · DOI · Paper page
  2. Yin, 2021, The mental health of women with polycystic ovary syndrome: A systematic review and meta-analysis, Arch. Womens Ment. Health, 24, 11, 10.1007/s00737-020-01043-x · DOI
  3. Cooney, 2017, Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment, Curr. Psychiatry Rep., 19, 83, 10.1007/s11920-017-0834-2 · DOI
  4. Abdalla, 2021, The Effect of Free Androgen Index on the Quality of Life of Women with Polycystic Ovary Syndrome: A Cross-Sectional Study, Front. Physiol., 12, 652559, 10.3389/fphys.2021.652559 · DOI · Paper page
  5. Fauser, 2012, Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Grou, Fertil. Steril., 97, 28, 10.1016/j.fertnstert.2011.09.024 · DOI · Paper page
  6. Panidis, 2014, The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome, Clin. Endocrinol., 80, 432, 10.1111/cen.12305 · DOI · Paper page
  7. Cheang, 2016, Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome, Int. J. Endocrinol., 2016, 7631804, 10.1155/2016/7631804 · DOI · Paper page
  8. Kowalska, 2001, Insulin, leptin, IGF-I and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome, Eur. J. Endocrinol., 144, 509, 10.1530/eje.0.1440509 · DOI
  9. Tolino, 2005, Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome, Eur. J. Obstet. Gynecol. Reprod. Biol., 119, 87, 10.1016/j.ejogrb.2004.06.043 · DOI · Paper page
  10. Hedenbro, 2018, Impact of diet and bariatric surgery on anti-Mullerian hormone levels, Hum. Reprod., 33, 690, 10.1093/humrep/dey032 · DOI
  11. Roelfsema, 2004, Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome, Am. J. Physiol. Endocrinol. Metab., 286, E615, 10.1152/ajpendo.00377.2003 · DOI · Paper page
  12. Rolland, 2014, Long-term weight loss maintenance and management following a VLCD: A 3-year outcome, Int. J. Clin. Pract., 68, 379, 10.1111/ijcp.12300 · DOI
  13. Dunaif, 2012, Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications, Endocr. Rev., 33, 981, 10.1210/er.2011-1034 · DOI · Paper page
  14. Lean, 1986, Prescription of diabetic diets in the 1980s, Lancet, 1, 723, 10.1016/S0140-6736(86)91111-6 · DOI
  15. Blumeyer, 2011, S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents, Br. J. Dermatol., 164, 5, 10.1111/j.1365-2133.2010.10011.x · DOI · Paper page
  16. Andersen, 1995, Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome, Metabolism, 44, 611, 10.1016/0026-0495(95)90118-3 · DOI · Paper page
  17. Suliburska, 2016, The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones in obese women of child-bearing age, Acta Sci. Pol. Technol. Aliment., 15, 213, 10.17306/J.AFS.2016.2.21 · DOI
  18. Davidson, 2014, Low glycemic index vegan or low-calorie weight loss diets for women with polycystic ovary syndrome: A randomized controlled feasibility study, Nutr. Res., 34, 552, 10.1016/j.nutres.2014.04.011 · DOI
  19. Li, 2021, Ketogenic diet in women with polycystic ovary syndrome and liver dysfunction who are obese: A randomized, open-label, parallel-group, controlled pilot trial, J. Obstet. Gynaecol. Res., 47, 1145, 10.1111/jog.14650 · DOI
  20. Marsh, 2005, The optimal diet for women with polycystic ovary syndrome?, Br. J. Nutr., 94, 154, 10.1079/BJN20051475 · DOI
  21. Bland, 2011, Comparisons against baseline within randomised groups are often used and can be highly misleading, Trials, 12, 264, 10.1186/1745-6215-12-264 · DOI
  22. Wahrenberg, 1999, Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 84, 2182
  23. Borruel, 2013, Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS), J. Clin. Endocrinol. Metab., 98, 1254, 10.1210/jc.2012-3698 · DOI · Paper page
  24. Romanowski, 2015, Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome, Arq. Gastroenterol., 52, 117, 10.1590/S0004-28032015000200008 · DOI
  25. Yildiran, 2019, Does increasing meal frequency improve weight loss and some biochemical parameters in overweight/obese females?, Nutr. Hosp., 36, 66
  26. Hamilton, 2013, The effects of weight loss on relative bone mineral density in premenopausal women, Obesity, 21, 441, 10.1002/oby.20052 · DOI
  27. Lim, 2019, Lifestyle changes in women with polycystic ovary syndrome, Cochrane Database Syst. Rev., 3, CD007506
  28. Lim, S., Smith, C.A., Costello, M.F., MacMillan, F., Moran, L., and Ee, C. (2019). Barriers and facilitators to weight management in overweight and obese women living in Australia with PCOS: A qualitative study. BMC Endocr. Disord., 19. · DOI · Paper page

Cited by

See all 33

Metadata

Authors
Deshmukh, H., Papageorgiou, M., Wells, L., Akbar, S., Strudwick, T., Deshmukh, K., Vitale, S. G., Rigby, A., Vince, R. V., Reid, M., & Sathyapalan, T.
Affiliations
  • Department of Academic Diabetes and Endocrinology, Allam Diabetes Centre, Hull University Teaching Hospitals NHS Trust, Hull HU3 2JZ, UK
  • Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
  • School of Sport, Exercise and Rehabilitation Sciences, University of Hull, Hull HU6 7 RX, UK
  • School of Psychology and Social Work, University of Hull, Hull HU6 7 RX, UK
  • Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09121 Cagliari, Italy
  • Institute of Clinical and Applied Health Research, Hull York Medical School, Hull HU6 7 RX, UK
Venue
Nutrients
Publisher
MDPI AG
Published
2023-09-06
Volume
15
Issue
18
Pages
3872
ISSN
2072-6643
Cited by
33
References
16
Language
en
Funders
  • an NIHR clinical lectureship
  • Hull University Teaching Hospitals NHS

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.